Rapid detection of toxigenic C. difficile
The Genspeed C.diff OneStep test identifies toxigenic C. difficile by combining detection of Glutamate Dehydrogenase (GDH), Toxin A, Toxin B and binary toxin in a single, molecular diagnostic test. The complete analysis including the detection on the Genspeed R2 analyser takes under 100 min. The new test addresses one of the most serious threats to healthcare systems worldwide, Clostridium difficile infection (CDI), which is believed to be the most common healthcareassociated infection. The disease is causing antibiotic-associated diarrhea (AAD) that may lead to pseudomembranous colitis and even to death. In a 2013 pub-lished report, the Center for Disease Control (CDC) in the USA categorized C. difficile infections as “Threat Level Urgent”, the highest level available. The Genspeed C.diff OneStep test features a simple, one-step molecular diagnostic test, avoiding the currently used sequential 2-step diagnostic test procedures which combine different test systems and assay principles for GDH and the C. difficile toxins. The rapid test provides conclusive results without the need for confirmatory re-testing and enables inter-laboratory comparisons of test results. Ready-touse reagents and automated dispensing minimize the number of manual process steps within the workflow. The Genspeed R2 analyser represents a reliable solution for customers interested in fast and accurate results. The virtually service-free system is simple to operate and is available at an attractive cost-benefit ratio. Genspeed products are currently available for sale in the EU and EFTA countries only. Availability in other countries outside the US is on request.
Supplier: GREINER BIO-ONE GMBH
Website:
